Prescribing analysis publications

In Focus report: Tramadol. This In Focus report includes supplementary information to that contained within the National Prescribing Indicators 2023-2024. Analysis of prescribing data to December 2023 report, to provide a more detailed picture of tramadol prescribing across Wales.

In Focus report: Phenoxymethylpenicillin (Penicillin V). This In Focus report is a standalone report looking at prescribing of phenoxymethylpenicillin (Penicillin V) across Wales.

In Focus report: Total opioid burden. This In Focus report includes supplementary information to that contained within the National Prescribing Indicators 2024-2025. Analysis of prescribing data to June 2024 report, to provide a more detailed picture of total opioid burden across Wales.

In Focus report: Hypnotics and anxiolytics. This In Focus report includes supplementary information to that contained within the National Prescribing Indicators 2024-2025. Analysis of prescribing data to December 2024 report, to provide a more detailed picture of hypnotics and anxiolytics prescribing across Wales.

This In Focus report includes supplementary information to that contained within the National Prescribing Indicators 2024-2025. Analysis of prescribing data to March 2024 report, to provide a more detailed picture of gabapentin and pregabalin prescribing across Wales.

Monthly summary reports on progress for increasing prescribing intervals within primary care in Wales.

Monthly reports on the carbon footprint of inhaler use within primary care in Wales.

AWTTC have developed the following annual prescribing reports for health boards in Wales. These are individualised, comparative reports that give the health board's ranking and progress with regard to a series of measures in relation to the other health boards.

This paper is intended to inform AWMSG of progress made in monitoring the usage of medicines appraised by AWMSG and the National Institute for Health and Care Excellence (NICE).

This document has been prepared by the Welsh Analytical Prescribing Support Unit (WAPSU) to provide a detailed analysis of diabetes therapeutic area prescribing at national, health board and GP cluster level.

This paper provides an analysis of primary care prescribing in Wales and England for medicines and preparations within the respiratory therapeutic area for the period July 2013–June 2014.